EndyMed Medical's Novel Multi-Source Radiofrequency Device Enables Real Time Skin Impedance Me... (built-in impedance measurement mechanism...)

EndyMed Medical's Novel Multi-Source Radiofrequency Device Enables Real Time Skin Impedance Measurements

Date:3/23/2011

built-in impedance measurement mechanism is a major advantage for the patients and physicians, globally, using EndyMed PRO."

Among the key highlights of this paper are the following points:

More than 6,000 unique skin impedance measurements on 22 patients were taken to substantiate the conclusions of this peer reviewed paper.
Data showed an average session impedance range was 215-584 Ohms with an average of 369 Ohms. Analysis of individual pulses (total of 6,000 readings) showed a significant decrease in impedance during the pulse. These findings validate the expected differences in skin impedance between individual patients and in the same patients during the treatment pulse.
The clinical study was based on 30 patients whose results showed a high predictability of efficacy (86.7% of patients had good results or better at 3 months follow-up and a decrease of 2 or more grades in Fitzpatrick's wrinkle scale).

EndyMed Medical's proprietary 3DEEP RF technology is a multi-source, phase-controlled radiofrequency energy source that is state-of-the-art, safe and effective. 3DEEP represents the latest development in the evolution of RF-based professional skin treatment systems. 3DEEP uses multiple RF sources and sophisticated software to effectively control the phase of the energy flowing between the handpiece electrodes. This method enables delivery of controlled heat deep into the skin, in a non-ablative or fractionally ablative way. 3DEEP technology is used in products which are FDA cleared and CE marked.

For more information, visit www.endymed.com or contact us at the contact details below.

About EndyMed Medical, Ltd.EndyMed Medical, Ltd. develops clinical solutions to rejuvenate aging and environmentally damaged skin. EndyMed is dedicated to providing the most effective products for the leadin
'/>"/>

SOURCE EndyMed
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Alzheimers Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
2. Novel Gene Therapy Agent NLX-P101 Effective in Treating Parkinsons Disease in Phase 2 Trial
3. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
4. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
5. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
6. Reportlinker Adds Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
7. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
10. Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
11. Novel Night Time Healing is Key to Shoulder Pain Relief From ROTATORELIEVER

Post Your Comments:

(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- It is no secret ... third being overweight or obese gyms and supplement companies are ... the condition is primarily related to dietary issues and a ... the result of a glandular problem or even a vitamin ... common vitamin deficiency is a lack of vitamin b12 ...

(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...

(Date:5/20/2013)... May 20, 2013 Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash. ... not conditional on due diligence. The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...

[0] USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss [0] Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio [0] Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash

... N.J., May 03, 2007 /PRNewswire-FirstCall/ --,Alpharma ... pharmaceutical company,through its Pharmaceuticals Division, this ... study of its investigational,abuse-deterrent, extended-release opioid ... the American Pain Society in Washington, ...

... /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced today that ... International Conference on Antiviral,Research being held in ... virus (HCV) polymerase inhibitor,discovered by Genelabs. , ... D. Roberts,Ph.D., Director of Medicinal Chemistry at ...

Cached Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2 Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3 Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4 Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2 Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3

Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting

(Date:5/20/2013)... 20, 2013 Dr. Robert Mokbel is ... trained to use the Laser Assisted New Attachment Procedure, ... patients with gum disease. LANAP may help many Fountain ... gum disease restore the jawbone support necessary to support ... of plaque and tartar in the mouth. Daily oral ...

(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 Daily Gossip, online ... provide its readers with useful tips that can help them ... , According to the website Natural Vitiligo Treatment System ... the numerous positive reviews it has received from the persons ... until now, but Daily Gossip has interviewed some of the ...

(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...

(Date:5/20/2013)... May 20, 2013 Mombo from ... national conference of the US Lactation Consultant Association (USLCA) ... including nurses, doctors and other health professionals. , ... at helping lactation professionals discover and learn about the ... of the most popular nursing pillows, which new mothers ...

Breaking Medicine News(10 mins):Health News:Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants 2 Health News:Combat Skin Cancer In Summer Months 2 Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2 Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2 Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2

[0] Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants [0] Combat Skin Cancer In Summer Months [0] New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine [0] Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com [0] Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference

... and ... IVUS, SAN DIEGO, Nov. 8 Volcano Corporation,(Nasdaq: ... measurement (FM) products designed to enhance the diagnosis and,treatment of ... quarter and first nine months of fiscal 2007. For ...

... Nabi ... Biologics to Biotest, BOCA RATON, Fla., ... third quarter,financial results. The company recorded a net loss of $15.9 ... which included,$7.5 million, or $0.12 per share, of expenses for unusual ...

... to Aid ... Decision-Making, MILFORD, Mass., ... Synapt(TM) HDMS,System to hasten its drug discovery efforts in the area ... C, HIV, osteoporosis, osteoarthritis, and high blood pressure.,Installed in June, the ...

... Hispanic youth report better dental health habits than their non-Hispanic ... researchers at Columbia University Mailman School of Public Health. ... the Journal of Health Care for the Poor and Underserved, ... community in America. , The study, a snapshot of more ...

... stomach-shielding drugs, patient health has suffered, researchers say , , ... Vioxx and Bextra off the market to spare patients, ... new study suggests. , Rates of gastrointestinal events serious ... cox-2 inhibitor medications were ordered off the market in ...

... have identified a way to detect neural progenitor cells ... system cells, in the living human brain using a ... The finding, supported by the National Institutes of Health ... depression, Parkinson,s disease, brain tumors, and a host of ...

Volcano Reports Record Third Quarter Revenues Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting Medivir Reshapes Drug Discovery Study of minority New York City youth finds unequal burden of poor dental health Vioxx Ban Tied to Rise in Serious GI Trouble Imaging neural progenitor cells in the living human brain

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Adenosine Deaminase, Body Fluid ADAMTS13 Activity & Inhibitor (VWF Cleaving Protease)Acylcarnitine Quantitative Profile, Plasma Acycloguanosine, Urine